Genosco is a clinical-stage biotech pursuing discovery and development of novel small-molecule drugs for patients with unmet medical needs. Our proprietary G-SMART™ platform enables discovery and optimization based on rare sequences in protein kinases that can be targeted to develop a highly selective compound.
This innovative approach has enabled us to build a strong portfolio of multiple independent and partnered pipelines. Our most advanced pipeline, Lazertinib, is currently undergoing phase 3 global clinical trial by Janssen and is also available in Korea for patients with EGFRm+ non-small cell lung cancer. Robust research and discovery programs are also underway.
With a shared mission to enhance people’s lives through innovative science, we are united in developing world-class precision medicine to help people have healthier and longer lives. Our interdisciplinary team consists of scientists with deep expertise in medicinal chemistry, structural & computational drug discovery design, cell biology, pharmacology, and drug metabolism.
Company Details
- Employees
- 28
- Founded
- -
- Address
- 43 Manning Rd, Billerica,ma 01821,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.genosco.com
- Keywords
- Billerica.
- HQ
- Billerica, MA
Genosco Questions
Genosco's website is http://www.genosco.com
Genosco's LinkedIn profile is https://www.linkedin.com/company/genosco
Genosco has
28 employees.
View email and phone details for 28
employees at Genosco.
Genosco's industry is
Biotechnology Research
Genosco's top competitors are
Oscotec Inc.,
Lg Chem Life Sciences Usa, Inc.,
Sword Bio,
Yuhan Corporation,
St Pharm,
Beantown Biotech,
Black Diamond Therapeutics,
Envol Biomedical,
Neosome Life Sciences,
Yuhan Usa.
Genosco's categories are Biotechnology Research
Genosco's founding year is 2008
